Gland Pharma Limited Gland Pharma Limited

Gland Pharma Limited

GLAND

Rankning i aktier #3302
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Aktiekurs
$32.32
Marknadsvärde
$5.33B
Förändring (1 dag)
-3.01%
Förändring (1 år)
47.99%
Land
IN
Handel Gland Pharma Limited (GLAND)

Kategori

Healthcare
P/S-tal för Gland Pharma Limited (GLAND)
P/S-tal per October 2026 TTM: 7.47
Enligt Gland Pharma Limited senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 7.47. I slutet av 2024 hade företaget ett P/S-tal på 5.27.
Historik för P/S-tal för Gland Pharma Limited från 2017 till 2026
P/S-tal vid årets slut
År P/S-tal Ändra
2026 (TTM) 7.47 63.72%
2025 4.56 -13.61%
2024 5.27 -9.26%
2023 5.81 -52.56%
2022 12.25 7.08%
2021 11.44 4.38%
2020 10.96 -26.45%
2019 14.91 -20.73%
2018 18.80 -1.35%
2017 19.06 0.00%
P/S-tal för liknande företag eller konkurrenter